Please login to the form below

Not currently logged in
Email:
Password:

Spirogen

This page shows the latest Spirogen news and features for those working in and with pharma, biotech and healthcare.

MedImmune partners with US National Cancer Institute

MedImmune partners with US National Cancer Institute

AZ boosted its pipeline in thsi area with the $440m acquisition of Spirogen.

Latest news

More from news
Approximately 1 fully matching, plus 8 partially matching documents found.

Latest Intelligence

  • Pharma deals during October 2013 Pharma deals during October 2013

    Auven's portfolio of companies includes Resolvyx, Kiacta, Kolitan and Sprout Pharmaceuticals, as well as Spirogen and ADC Therapeutics. ... The Spirogen/Auven Therapeutics deal with MedImmune discussed above re-confirms that ADC technology is certainly

  • Deal Watch table for October 2013 Deal Watch table for October 2013

    730. Spirogen / MedImmune. Acquisition. ADC technology - oncology (lead asset in phase II).

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Ashfield

Transforming healthcare outsourcing. From small beginnings in 1997, Ashfield has grown rapidly into an international healthcare services organisation. By anticipating...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics